5Semeraro N, Ammollo CT, Semeraro F, et al. Sepsis, thrombosis and organ dysfimction[J]. Thromb Res, 2012, 129(3):290-295.
6Japiass0 AM, Salluh JI, Bozza PT, et al. Revisiting steroid treatment for septic shock: molecular actions and clinical effects--a review[J]. Mem lnst Oswaldo Cruz, 2009, 104(4):531-548.
7Yamada T, Yamada T, Yamamura MK, et al. Invasive group A strep- tococcal infection in pregnancy[J]. J Infect, 2010, 60(6):417-424.
8Henningham A, Barnett TC, Maamary PG, et al. Pathogenesis of group A streptococcal infections[J]. Discov Med, 2012, 13(72):329-342.
9Beyer I, Bautmans I, Njemini R, et al. Effects on muscle performance of NSAID treatment with piroxicam versus placebo in geriatric pa- tients with acute infection-induced inflammation. A double blind ran'domized controlled trial [J]. BMC Musculoskelet Disord, 201 l, 12: 292.
10Soares MO, Welton N J, Harrison DA, et al. An evaluation of the feasi- bility, cost and value of information ofa multicentre randomised con- trolled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis [J]. Health Technol Assess, 2012, 16 (7):1-186.
